Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Scientific Reports|March 17, 2021
Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2Tomokazu Nunoue, Satoshi Yamaguchi, Sanae Teshigawara, et al.
Hepato-Gastroenterology|February 21, 2015
Monopolar soft-mode coagulation using hemostatic forceps for peptic ulcer bleedingYasushi Yamasaki, Ryuta Takenaka, Tomokazu Nunoue, et al.
CEN Case Reports|May 17, 2017
Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndromeMasafumi Tenta, Haruhito Adam Uchida, Tomokazu Nunoue, et al.
Kidney International Reports|July 9, 2025
Dotinurad Treatment for Patients With Hyperuricemia Complicating CKDKatsuyuki Tanabe, Tomokazu Nunoue, Naoki Itabashi, et al.
Advances in Therapy|September 7, 2022
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective StudyHaruhito A Uchida, Hirofumi Nakajima, Masami Hashimoto, et al.
Metabolism: Clinical and Experimental|March 10, 2015
Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetesYu Wang, Akihiro Katayama, Takahiro Terami, et al.
Scientific Reports|November 20, 2015
Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitisAkihiro Katayama, Atsuko Nakatsuka, Jun Eguchi, et al.
Journal of Clinical Gastroenterology|August 2, 2014
A Randomized Trial of Monopolar Soft-mode Coagulation Versus Heater Probe Thermocoagulation for Peptic Ulcer BleedingTomokazu Nunoue, Ryuta Takenaka, Keisuke Hori, et al.
Frontiers in Cardiovascular Medicine|June 10, 2021
Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2)Koki Mise, Mariko Imamura, Satoshi Yamaguchi, et al.
BMJ Open Diabetes Research & Care|May 30, 2024
Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)Asami Ueno, Yasuhiro Onishi, Koki Mise, et al.
Pageof 2